Mesenchymal Stem Cell-Derived Exosomes: A Promising Therapeutic Strategy for Age-Related Diseases

Abstract

The global increase in the aging population has led to a concurrent rise in the incidence of age-related diseases, posing substantial challenges to healthcare systems and affecting the well-being of the elderly. Identifying and securing effective treatments has become an urgent priority. In this context, mesenchymal stem cell-derived exosomes (MSC-Exos) have emerged as a promising and innovative modality in the field of anti-aging medicine, offering a multifaceted therapeutic approach. MSC-Exos demonstrate significant potential due to their immunomodulatory and anti-inflammatory properties, their ability to inhibit oxidative stress, and their reparative effects on senescent tissues. These attributes make them valuable in combating a range of conditions associated with aging, such as cardiovascular diseases, neurodegeneration, skin aging, and osteoarthritis. The integration of exosomes with membrane-penetrating peptides introduces a novel strategy for the delivery of biomolecules, surmounting traditional cellular barriers and enhancing therapeutic efficacy. This review provides a comprehensive synthesis of the current understanding of MSC-Exos, underscoring their role as a novel and potent therapeutic strategy against the intricate challenges of age-related diseases.

Keywords

exosome / immunomodulatory / mesenchymal stem cell / senescence / tissue regeneration

References

[1] C. López-Otin, C. López-Otín, M. A. Blasco, L. Partridge, M. Serrano, and G. Kroemer, “Hallmarks of Aging: An Expanding Universe,” Cell 186, no. 2 (2023): 243-278.

[2] International Society for Cellular Therapy Annual Meeting, Berlin, Germany, 2006 Abstracts, Cytotherapy 8, no. Suppl 1 (2006): 80.

[3] M. Dominici, K. le Blanc, I. Mueller, et al., “Minimal Criteria for Defining Multipotent Mesenchymal Stromal Cells. The International Society for Cellular Therapy Position Statement,” Cytotherapy 8, no. 4 (2006): 315-317.

[4] M. Mazzella, K. Walker, C. Cormier, et al., “Regulation of Self-Renewal and Senescence in Primitive Mesenchymal Stem Cells by Wnt and TGFβ Signaling,” Stem Cell Research & Therapy 14, no. 1 (2023): 305.

[5] R. Sarugaser, L. Hanoun, A. Keating, W. L. Stanford, and J. E. Davies, “Human Mesenchymal Stem Cells Self-Renew and Differentiate According to a Deterministic Hierarchy,” PLoS One 4, no. 8 (2009): e6498.

[6] M. S. Kahrizi, E. Mousavi, A. Khosravi, et al., “Recent Advances in Pre-Conditioned Mesenchymal Stem/Stromal Cell (MSCs) Therapy in Organ Failure; a Comprehensive Review of Preclinical Studies,” Stem Cell Research and Therapy 14, no. 1 (2023): 155.

[7] T. Zhou, Z. Yuan, J. Weng, et al., “Challenges and Advances in Clinical Applications of Mesenchymal Stromal Cells,” Journal of Hematology and Oncology 14, no. 1 (2021): 24.

[8] S. V. Boregowda, C. N. Booker, and D. G. Phinney, “Mesenchymal Stem Cells: The Moniker Fits the Science,” Stem Cells 36, no. 1 (2018): 7-10.

[9] Y. Seo, M. Kang, and H. Kim, “Strategies to Potentiate Paracrine Therapeutic Efficacy of Mesenchymal Stem Cells in Inflammatory Diseases,” International Journal of Molecular Sciences 22, no. 7 (2021): 3397.

[10] H. S. Joo, J. H. Suh, H. J. Lee, E. S. Bang, and J. M. Lee, “Current Knowledge and Future Perspectives on Mesenchymal Stem Cell-Derived Exosomes as a New Therapeutic Agent,” International Journal of Molecular Sciences 21, no. 3 (2020): 727.

[11] Z. Liu, Y. Xu, Y. Wan, J. Gao, Y. Chu, and J. Li, “Exosomes From Adipose-Derived Mesenchymal Stem Cells Prevent Cardiomyocyte Apoptosis Induced by Oxidative Stress,” Cell Death Discovery 5 (2019): 5.

[12] Y. Huang, K. Liu, Q. Li, Y. Yao, and Y. Wang, “Exosomes Function in Tumor Immune Microenvironment,” Advances in experimental medicine and biology 1056 (2018): 109-122.

[13] S. W. Ferguson and J. Nguyen, “Exosomes as Therapeutics: The Implications of Molecular Composition and Exosomal Heterogeneity,” Journal of Controlled Release 228 (2016): 179-190.

[14] Y. An, S. Lin, X. Tan, et al., “Exosomes From Adipose-Derived Stem Cells and Application to Skin Wound Healing,” Cell Proliferation 54, no. 3 (2021): e12993.

[15] T. Wang, T. Li, X. Niu, et al., “ADSC-Derived Exosomes Attenuate Myocardial Infarction Injury by Promoting miR-205-Mediated Cardiac Angiogenesis,” Biology Direct 18, no. 1 (2023): 6.

[16] A. Sivanantham and Y. Jin, “Impact of Storage Conditions on EV Integrity/Surface Markers and Cargos,” Life 12, no. 5 (2022): 697.

[17] J. Y. Wu, Y. J. Li, X. B. Hu, S. Huang, and D. X. Xiang, “Preservation of Small Extracellular Vesicles for Functional Analysis and Therapeutic Applications: A Comparative Evaluation of Storage Conditions,” Drug Delivery 28, no. 1 (2021): 162-170.

[18] S. Ghafouri-Fard, V. Niazi, B. M. Hussen, M. D. Omrani, M. Taheri, and A. Basiri, “The Emerging Role of Exosomes in the Treatment of Human Disorders With a Special Focus on Mesenchymal Stem Cells-Derived Exosomes,” Frontiers in Cell and Developmental Biology 9 (2021): 653296.

[19] D. Wu, Q. Chen, X. Chen, F. Han, Z. Chen, and Y. Wang, “The Blood-Brain Barrier: Structure, Regulation, and Drug Delivery,” Signal Transduction and Targeted Therapy 8, no. 1 (2023): 217.

[20] P. Mohapatra, M. Gopikrishnan, G. P. Doss C, and N. Chandrasekaran, “How Precise Are Nanomedicines in Overcoming the Blood-Brain Barrier? A Comprehensive Review of the Literature,” International Journal of Nanomedicine 19 (2024): 2441-2467.

[21] D. G. Phinney and M. F. Pittenger, “Concise Review: MSC-Derived Exosomes for Cell-Free Therapy,” Stem Cells 35, no. 4 (2017): 851-858.

[22] F. Vakhshiteh, F. Atyabi, and S. N. Ostad, “Mesenchymal Stem Cell Exosomes: A Two-Edged Sword in cancer Therapy,” International Journal of Nanomedicine 14 (2019): 2847-2859.

[23] Z. Weng, B. Zhang, C. Wu, et al., “Therapeutic Roles of Mesenchymal Stem Cell-Derived Extracellular Vesicles in Cancer,” Journal of Hematology and Oncology 14, no. 1 (2021): 136.

[24] Y. J. Lee, K. J. Shin, and Y. C. Chae, “Regulation of Cargo Selection in Exosome Biogenesis and Its Biomedical Applications in Cancer,” Experimental and Molecular Medicine 56, no. 4 (2024): 877-889.

[25] J. C. Akers, D. Gonda, R. Kim, B. S. Carter, and C. C. Chen, “Biogenesis of Extracellular Vesicles (EV): Exosomes, Microvesicles, Retrovirus-Like Vesicles, and Apoptotic Bodies,” Journal of Neuro-Oncology 113, no. 1 (2013): 1-11.

[26] H. I. Kim, J. Park, Y. Zhu, X. Wang, Y. Han, and D. Zhang, “Recent Advances in Extracellular Vesicles for Therapeutic Cargo Delivery,” Experimental and Molecular Medicine 56, no. 4 (2024): 836-849.

[27] A. C. Dixson, T. R. Dawson, D. di Vizio, and A. M. Weaver, “Context-Specific Regulation of Extracellular Vesicle Biogenesis and Cargo Selection,” Nature Reviews. Molecular Cell Biology 24, no. 7 (2023): 454-476.

[28] Y. Tang, Y. Zhou, and H. J. Li, “Advances in Mesenchymal Stem Cell Exosomes: A Review,” Stem Cell Research and Therapy 12, no. 1 (2021): 71.

[29] Z. Qiu, Z. Zhong, Y. Zhang, H. Tan, B. Deng, and G. Meng, “Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomal miR-335-5p Attenuates the Inflammation and Tubular Epithelial-Myofibroblast Transdifferentiation of Renal Tubular Epithelial Cells by Reducing ADAM19 Protein Levels,” Stem Cell Research and Therapy 13, no. 1 (2022): 373.

[30] D. Wang, Q. Na, G. Y. Song, and L. Wang, “Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosome-Mediated Transfer of microRNA-133b Boosts Trophoblast Cell Proliferation, Migration and Invasion in Preeclampsia by Restricting SGK1,” Cell Cycle 19, no. 15 (2020): 1869-1883.

[31] V. Álvarez-Garcia, Y. Tawil, H. M. Wise, and N. R. Leslie, “Mechanisms of PTEN Loss in Cancer: It's All About Diversity,” Seminars in Cancer Biology 59 (2019): 66-79.

[32] Z. Yao, J. Li, H. Xiong, et al., “MicroRNA Engineered Umbilical Cord Stem Cell-Derived Exosomes Direct Tendon Regeneration by mTOR Signaling,” Journal of Nanobiotechnology 19, no. 1 (2021): 169.

[33] L. Pi, L. Yang, B. R. Fang, X. X. Meng, and L. Qian, “Exosomal microRNA-125a-3p From Human Adipose-Derived Mesenchymal Stem Cells Promotes Angiogenesis of Wound Healing Through Inhibiting PTEN,” Molecular and Cellular Biochemistry 477, no. 1 (2022): 115-127.

[34] Y. Yang, Y. Li, S. Zhang, L. Cao, Y. Zhang, and B. Fang, “miR-199a-5p From Bone Marrow Mesenchymal Stem Cell Exosomes Promotes the Proliferation of Neural Stem Cells by Targeting GSK-3β,” Acta Biochimica et Biophysica Sinica Shanghai 55, no. 5 (2023): 783-794.

[35] L. Zhang, W. Bai, Y. Peng, Y. Lin, and M. Tian, “Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Provide Neuroprotection in Traumatic Brain Injury Through the lncRNA TUBB6/Nrf2 Pathway,” Brain Research 1824 (2024): 148689.

[36] Y. Yu, M. Chen, Q. Guo, et al., “Human Umbilical Cord Mesenchymal Stem Cell Exosome-Derived miR-874-3p Targeting RIPK1/PGAM5 Attenuates Kidney Tubular Epithelial Cell Damage,” Cellular and Molecular Biology Letters 28, no. 1 (2023): 12.

[37] Z. Wang, D. Gao, S. Wang, H. Lin, Y. Wang, and W. Xu, “Exosomal microRNA-1246 From Human Umbilical Cord Mesenchymal Stem Cells Potentiates Myocardial Angiogenesis in Chronic Heart Failure,” Cell Biology International 45, no. 11 (2021): 2211-2225.

[38] Y. Xu, Y. Lai, L. Cao, et al., “Human Umbilical Cord Mesenchymal Stem Cells-Derived Exosomal microRNA-451a Represses Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma Cells by Inhibiting ADAM10,” RNA Biology 18, no. 10 (2021): 1408-1423.

[39] X. Li, L. Liu, J. Yang, et al., “Exosome Derived From Human Umbilical Cord Mesenchymal Stem Cell Mediates MiR-181c Attenuating Burn-Induced Excessive Inflammation,” eBioMedicine 8 (2016): 72-82.

[40] Z. Zhang, X. Zou, R. Zhang, et al., “Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomal miR-146a-5p Reduces Microglial-Mediated Neuroinflammation via Suppression of the IRAK1/TRAF6 Signaling Pathway After Ischemic Stroke,” Aging (Albany NY) 13, no. 2 (2021): 3060-3079.

[41] Y. T. Sun, J. H. Cai, and S. Bao, “Overexpression of lncRNA HCP5 in Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Promoted the Proliferation and Inhibited the Apoptosis of Ovarian Granulosa Cells via the Musashi RNA-Binding Protein 2/Oestrogen Receptor Alpha 1 axis,” Endocrine Journal 69, no. 9 (2022): 1117-1129.

[42] C. Ding, L. Zhu, H. Shen, et al., “Exosomal miRNA-17-5p Derived From Human Umbilical Cord Mesenchymal Stem Cells Improves Ovarian Function in Premature Ovarian Insufficiency by Regulating SIRT7,” Stem Cells 38, no. 9 (2020): 1137-1148.

[43] M. Song, L. Ma, Y. Zhu, H. Gao, and R. Hu, “Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Inhibits Fibrosis in Human Endometrial Stromal Cells via miR-140-3p/FOXP1/Smad Axis,” Scientific Reports 14, no. 1 (2024): 8321.

[44] Q. Shi, D. Wang, X. Ding, X. Yang, and Y. Zhang, “Exosome-Shuttled miR-7162-3p From Human Umbilical Cord Derived Mesenchymal Stem Cells Repair Endometrial Stromal Cell Injury by Restricting APOL6,” Archives of Biochemistry and Biophysics 707 (2021): 108887.

[45] Y. Huang, L. Chen, D. Chen, P. Fan, and H. Yu, “Exosomal microRNA-140-3p From Human Umbilical Cord Mesenchymal Stem Cells Attenuates Joint Injury of Rats With Rheumatoid Arthritis by Silencing SGK1,” Molecular Medicine 28, no. 1 (2022): 36.

[46] T. Jiao, Y. Huang, H. Sun, and L. Yang, “Exosomal Lnc-CDHR Derived From Human Umbilical Cord Mesenchymal Stem Cells Attenuates Peritoneal Epithelial-Mesenchymal Transition Through AKT/FOXO Pathway,” Aging (Albany NY) 15, no. 14 (2023): 6921-6932.

[47] H. Gao, Z. Yu, Y. Li, and X. Wang, “miR-100-5p in Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Mediates Eosinophilic Inflammation to Alleviate Atherosclerosis via the FZD5/Wnt/β-Catenin Pathway,” Acta Biochimica et Biophysica Sinica Shanghai 53, no. 9 (2021): 1166-1176.

[48] L. Diao and Q. Zhang, “Transfer of lncRNA UCA1 by hUCMSCs-Derived Exosomes Protects Against Hypoxia/Reoxygenation Injury Through Impairing miR-143-Targeted Degradation of Bcl-2,” Aging (Albany NY) 13, no. 4 (2021): 5967-5985.

[49] C. Gong, Z. Gu, X. Zhang, et al., “HMSCs Exosome-Derived miR-199a-5p Attenuates Sulfur Mustard-Associated Oxidative Stress via the CAV1/NRF2 Signalling Pathway,” Journal of Cellular and Molecular Medicine 27, no. 15 (2023): 2165-2182.

[50] S. Wang, T. Liu, N. Nan, et al., “Exosomes From Human Umbilical Cord Mesenchymal Stem Cells Facilitates Injured Endometrial Restoring in Early Repair Period Through miR-202-3p Mediating Formation of ECM,” Stem Cell Reviews and Reports 19, no. 6 (2023): 1954-1964.

[51] X. Du, H. Li, X. Han, and W. Ma, “Mesenchymal Stem Cells-Derived Exosomal miR-24-3p Ameliorates Non-alcohol Fatty Liver Disease by Targeting Keap-1,” Biochemical and Biophysical Research Communications 637 (2022): 331-340.

[52] L. Li, X. Zhang, and Y. Chen, “Human Umbilical Cord Mesenchymal Stem Cell Exosome-Derived miR-335-5p Alleviated Lipopolysaccharide-Induced Acute Lung Injury by Regulating the m6A Level of ITGβ4 Gene,” Current Medicinal Chemistry 31 (2024): 5448-5467.

[53] W. Zhang, Y. Wang, and Y. Kong, “Exosomes Derived From Mesenchymal Stem Cells Modulate miR-126 to Ameliorate Hyperglycemia-Induced Retinal Inflammation via Targeting HMGB1,” Investigative Ophthalmology and Visual Science 60, no. 1 (2019): 294-303.

[54] B. Zhu, L. Zhang, C. Liang, et al., “Stem Cell-Derived Exosomes Prevent Aging-Induced Cardiac Dysfunction Through a Novel Exosome/lncRNA MALAT1/NF-κB/TNF-α Signaling Pathway,” Oxidative Medicine and Cellular Longevity 2019 (2019): 9739258.

[55] M. Shao, Q. Xu, Z. Wu, et al., “Exosomes Derived From Human Umbilical Cord Mesenchymal Stem Cells Ameliorate IL-6-Induced Acute Liver Injury Through miR-455-3p,” Stem Cell Research and Therapy 11, no. 1 (2020): 37.

[56] X. Li, Y. Wang, Z. Cai, Q. Zhou, L. Li, and P. Fu, “Exosomes From Human Umbilical Cord Mesenchymal Stem Cells Inhibit ROS Production and Cell Apoptosis in Human Articular Chondrocytes Via the miR-100-5p/NOX4 Axis,” Cell Biology International 45, no. 10 (2021): 2096-2106.

[57] J. H. Cai, Y. T. Sun, and S. Bao, “HucMSCs-Exosomes Containing miR-21 Promoted Estrogen Production in Ovarian Granulosa Cells via LATS1-Mediated Phosphorylation of LOXL2 and YAP,” General and Comparative Endocrinology 321 (2022): 114015.

[58] F. Cheng, F. Yang, Y. Wang, J. Zhou, H. Qian, and Y. Yan, “Mesenchymal Stem Cell-Derived Exosomal miR-27b-3p Alleviates Liver Fibrosis Via Downregulating YAP/LOXL2 Pathway,” Journal of Nanobiotechnology 21, no. 1 (2023): 195.

[59] W. Liu, N. Zhou, Y. Liu, et al., “Mesenchymal Stem Cell Exosome-Derived miR-223 Alleviates Acute Graft-Versus-Host Disease via Reducing the Migration of Donor T Cells,” Stem Cell Research and Therapy 12, no. 1 (2021): 153.

[60] X. J. Song, L. Zhang, Q. Li, Y. Li, F. H. Ding, and X. Li, “hUCB-MSC Derived Exosomal miR-124 Promotes Rat Liver Regeneration After Partial Hepatectomy Via Downregulating Foxg1,” Life Sciences 265 (2021): 118821.

[61] S. C. Hao, H. Ma, Z. F. Niu, S. Y. Sun, Y. R. Zou, and H. C. Xia, “hUC-MSCs Secreted Exosomes Inhibit the Glioma Cell Progression Through PTENP1/miR-10a-5p/PTEN Pathway,” European Review for Medical and Pharmacological Sciences 23, no. 22 (2019): 10013-10023.

[62] Y. Lu, Y. Wei, X. Shen, et al., “Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles Improve Ovarian Function in Rats With Primary Ovarian Insufficiency by Carrying miR-145-5p,” Journal of Reproductive Immunology 158 (2023): 103971.

[63] Y. Huang, J. Ma, Y. Fan, and L. Yang, “Mechanisms of Human Umbilical Cord Mesenchymal Stem Cells-Derived Exosomal lncRNA GAS5 in Alleviating EMT of HPMCs via Wnt/β-Catenin Signaling Pathway,” Aging (Albany NY) 15, no. 10 (2023): 4144-4158.

[64] B. C. Yang, M. J. Kuang, J. Y. Kang, J. Zhao, J. X. Ma, and X. L. Ma, “Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Act via the miR-1263/Mob1/Hippo Signaling Pathway to Prevent Apoptosis in Disuse Osteoporosis,” Biochemical and Biophysical Research Communications 524, no. 4 (2020): 883-889.

[65] P. Wu, B. Zhang, X. Han, et al., “HucMSC Exosome-Delivered 14-3-3ζ Alleviates Ultraviolet Radiation-Induced Photodamage via SIRT1 Pathway Modulation,” Aging (Albany NY) 13, no. 8 (2021): 11542-11563.

[66] B. Zhang, Y. Shi, A. Gong, et al., “HucMSC Exosome-Delivered 14-3-3ζ Orchestrates Self-Control of the Wnt Response via Modulation of YAP During Cutaneous Regeneration,” Stem Cells 34, no. 10 (2016): 2485-2500.

[67] J. Wang, H. Jia, B. Zhang, et al., “HucMSC Exosome-Transported 14-3-3ζ Prevents the Injury of Cisplatin to HK-2 Cells by Inducing Autophagy In Vitro,” Cytotherapy 20, no. 1 (2018): 29-44.

[68] S. Yang, X. Liang, J. Song, et al., “A Novel Therapeutic Approach for Inflammatory Bowel Disease by Exosomes Derived From Human Umbilical Cord Mesenchymal Stem Cells to Repair Intestinal Barrier via TSG-6,” Stem Cell Research and Therapy 12, no. 1 (2021): 315.

[69] Y. Yan, W. Jiang, Y. Tan, et al., “hucMSC Exosome-Derived GPX1 Is Required for the Recovery of Hepatic Oxidant Injury,” Molecular Therapy 25, no. 2 (2017): 465-479.

[70] P. Liu, Q. Zhang, J. Mi, et al., “Exosomes Derived From Stem Cells of Human Deciduous Exfoliated Teeth Inhibit Angiogenesis In Vivo and In Vitro Via the Transfer of miR-100-5p and miR-1246,” Stem Cell Research and Therapy 13, no. 1 (2022): 89.

[71] C. Yang, W. Lim, J. Park, S. Park, S. You, and G. Song, “Anti-Inflammatory Effects of Mesenchymal Stem Cell-Derived Exosomal microRNA-146a-5p and microRNA-548e-5p on Human Trophoblast Cells,” Molecular Human Reproduction 25, no. 11 (2019): 755-771.

[72] R. Yuan, X. Dai, Y. Li, C. Li, and L. Liu, “Exosomes From miR-29a-Modified Adipose-Derived Mesenchymal Stem Cells Reduce Excessive Scar Formation by Inhibiting TGF-β2/Smad3 Signaling,” Molecular Medicine Reports 24, no. 5 (2021): 758.

[73] Y. Fu, Y. L. Zhang, R. Q. Liu, et al., “Exosome lncRNA IFNG-AS1 Derived From Mesenchymal Stem Cells of Human Adipose Ameliorates Neurogenesis and ASD-Like Behavior in BTBR Mice,” Journal of Nanobiotechnology 22, no. 1 (2024): 66.

[74] W. Qian, L. Huang, Y. Xu, et al., “Hypoxic ASCs-Derived Exosomes Attenuate Colitis by Regulating Macrophage Polarization Via miR-216a-5p/HMGB1 Axis,” Inflammatory Bowel Diseases 29, no. 4 (2023): 602-619.

[75] Q. Zhang, P. Su, F. Zhao, et al., “Enhancing Skin Injury Repair: Combined Application of PF-127 Hydrogel and hADSC-Exos Containing miR-148a-3p,” ACS Biomaterials Science and Engineering 10, no. 4 (2024): 2235-2250.

[76] Y. Sun, Y. Ju, and B. Fang, “Exosomes From Human Adipose-Derived Mesenchymal Stromal/Stem Cells Accelerate Angiogenesis in Wound Healing: Implication of the EGR-1/lncRNA-SENCR/DKC1/VEGF-A Axis,” Human Cell 35, no. 5 (2022): 1375-1390.

[77] Y. Han, J. Ren, Y. Bai, X. Pei, and Y. Han, “Exosomes From Hypoxia-Treated Human Adipose-Derived Mesenchymal Stem Cells Enhance Angiogenesis Through VEGF/VEGF-R,” International Journal of Biochemistry and Cell Biology 109 (2019): 59-68.

[78] Y. Song, H. Dou, X. Li, et al., “Exosomal miR-146a Contributes to the Enhanced Therapeutic Efficacy of Interleukin-1β-Primed Mesenchymal Stem Cells Against Sepsis,” Stem Cells 35, no. 5 (2017): 1208-1221.

[79] M. Yang, L. Lin, C. Sha, et al., “Bone Marrow Mesenchymal Stem Cell-Derived Exosomal miR-144-5p Improves Rat Ovarian Function After Chemotherapy-Induced Ovarian Failure by Targeting PTEN,” Laboratory Investigation 100, no. 3 (2020): 342-352.

[80] Y. Wang, W. Chen, L. Zhao, et al., “Obesity Regulates miR-467/HoxA10 axis on Osteogenic Differentiation and Fracture Healing by BMSC-Derived Exosome LncRNA H19,” Journal of Cellular and Molecular Medicine 25, no. 3 (2021): 1712-1724.

[81] T. Wu, Q. Tian, R. Liu, et al., “Inhibitory Role of Bone Marrow Mesenchymal Stem Cells-Derived Exosome in Non-Small-Cell Lung Cancer: microRNA-30b-5p, EZH2 and PI3K/AKT Pathway,” Journal of Cellular and Molecular Medicine 27, no. 22 (2023): 3526-3538.

[82] X. Shen, J. Qin, Z. Wei, and F. Liu, “Bone Marrow Mesenchymal Stem Cell Exosome-Derived lncRNA TUC339 Influences the Progression of Osteoarthritis by Regulating Synovial Macrophage Polarization and Chondrocyte Apoptosis,” Biomedicine and Pharmacotherapy 167 (2023): 115488.

[83] S. Ma, S. Li, Y. Zhang, et al., “BMSC-Derived Exosomal CircHIPK3 Promotes Osteogenic Differentiation of MC3T3-E1 Cells via Mitophagy,” International Journal of Molecular Sciences 24, no. 3 (2023): 2785.

[84] L. Wen, Y. D. Wang, D. F. Shen, et al., “Exosomes Derived From Bone Marrow Mesenchymal Stem Cells Inhibit Neuroinflammation After Traumatic Brain Injury,” Neural Regeneration Research 17, no. 12 (2022): 2717-2724.

[85] Z. L. Sun, T. You, B. H. Zhang, Y. Liu, and J. Liu, “Bone Marrow Mesenchymal Stem Cell-Derived Exosomes miR-202-5p Inhibited Pyroptosis to Alleviate Lung Ischemic-Reperfusion Injury by Targeting CMPK2,” Kaohsiung Journal of Medical Sciences 39, no. 7 (2023): 688-698.

[86] J. Wang, J. Wang, Y. Wang, et al., “Bone Marrow Mesenchymal Stem Cells-Derived miR-21-5p Protects Grafted Islets Against Apoptosis by Targeting PDCD4,” Stem Cells 41, no. 2 (2023): 169-183.

[87] Z. Wen, Z. Mai, X. Zhu, et al., “Mesenchymal Stem Cell-Derived Exosomes Ameliorate Cardiomyocyte Apoptosis in Hypoxic Conditions Through microRNA144 by Targeting the PTEN/AKT Pathway,” Stem Cell Research and Therapy 11, no. 1 (2020): 36.

[88] X. Chen, Y. Shi, P. Xue, X. Ma, J. Li, and J. Zhang, “Mesenchymal Stem Cell-Derived Exosomal microRNA-136-5p Inhibits Chondrocyte Degeneration in Traumatic Osteoarthritis by Targeting ELF3,” Arthritis Research and Therapy 22, no. 1 (2020): 256.

[89] B. Lei, X. Wu, K. Xia, H. Sun, and J. Wang, “Exosomal Micro-RNA-96 Derived From Bone Marrow Mesenchymal Stem Cells Inhibits Doxorubicin-Induced Myocardial Toxicity by Inhibiting the Rac1/Nuclear Factor-κB Signaling Pathway,” Journal of the American Heart Association 10, no. 17 (2021): e020589.

[90] Y. Huang, X. Zhang, J. Zhan, et al., “Bone Marrow Mesenchymal Stem Cell-Derived Exosomal miR-206 Promotes Osteoblast Proliferation and Differentiation in Osteoarthritis by Reducing Elf3,” Journal of Cellular and Molecular Medicine 25, no. 16 (2021): 7734-7745.

[91] R. Li, K. Zhao, Q. Ruan, C. Meng, and F. Yin, “Bone Marrow Mesenchymal Stem Cell-Derived Exosomal microRNA-124-3p Attenuates Neurological Damage in Spinal Cord Ischemia-Reperfusion Injury by Downregulating Ern1 and Promoting M2 Macrophage Polarization,” Arthritis Research and Therapy 22, no. 1 (2020): 75.

[92] X. Xie, Y. Cao, L. Dai, and D. Zhou, “Bone Marrow Mesenchymal Stem Cell-Derived Exosomal lncRNA KLF3-AS1 Stabilizes Sirt1 Protein to Improve Cerebral Ischemia/Reperfusion Injury via miR-206/USP22 axis,” Molecular Medicine 29, no. 1 (2023): 3.

[93] L. Li and J. Ge, “Exosome-Derived lncRNA-Ankrd26 Promotes Dental Pulp Restoration by Regulating miR-150-TLR4 Signaling,” Molecular Medicine Reports 25, no. 5 (2022): 152.

[94] C. Franceschi, P. Garagnani, G. Vitale, M. Capri, and S. Salvioli, “Inflammaging and 'Garb-aging',” Trends in Endocrinology and Metabolism 28, no. 3 (2017): 199-212.

[95] X. Li, C. Li, W. Zhang, et al., “Inflammation and Aging: Signaling Pathways and Intervention Therapies,” Signal Transduction and Targeted Therapy 8, no. 1 (2023): 239.

[96] J. J. Baechle, N. Chen, P. Makhijani, S. Winer, D. Furman, and D. A. Winer, “Chronic Inflammation and the Hallmarks of Aging,” Molecular Metabolism 74 (2023): 101755.

[97] A. G. Stewart, B. Thomas, and J. Koff, “TGF-β: Master Regulator of Inflammation and Fibrosis,” Respirology 23, no. 12 (2018): 1096-1097.

[98] M. Xie, W. Xiong, Z. She, et al., “Immunoregulatory Effects of Stem Cell-Derived Extracellular Vesicles on Immune Cells,” Frontiers in Immunology 11 (2020): 13.

[99] A. Mokarizadeh, N. Delirezh, A. Morshedi, G. Mosayebi, A. A. Farshid, and K. Mardani, “Microvesicles Derived From Mesenchymal Stem Cells: Potent Organelles for Induction of Tolerogenic Signaling,” Immunology Letters 147, no. 1-2 (2012): 47-54.

[100] S. J. Liu, M. Y. Meng, S. Han, et al., “Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Ameliorate HaCaT Cell Photo-Aging,” Rejuvenation Research 24, no. 4 (2021): 283-293.

[101] N. Heidari, H. Abbasi-Kenarsari, S. Namaki, et al., “Adipose-Derived Mesenchymal Stem Cell-Secreted Exosome Alleviates Dextran Sulfate Sodium-Induced Acute Colitis by Treg Cell Induction and Inflammatory Cytokine Reduction,” Journal of Cellular Physiology 236, no. 8 (2021): 5906-5920.

[102] S. Nojehdehi, S. Soudi, A. Hesampour, S. Rasouli, M. Soleimani, and S. M. Hashemi, “Immunomodulatory Effects of Mesenchymal Stem Cell-Derived Exosomes on Experimental Type-1 Autoimmune Diabetes,” Journal of Cellular Biochemistry 119, no. 11 (2018): 9433-9443.

[103] H. Zhao, Q. Shang, Z. Pan, et al., “Exosomes From Adipose-Derived Stem Cells Attenuate Adipose Inflammation and Obesity Through Polarizing M2 Macrophages and Beiging in White Adipose Tissue,” Diabetes 67, no. 2 (2018): 235-247.

[104] H. Padinharayil, J. Varghese, C. Wilson, and A. George, “Mesenchymal Stem Cell-Derived Exosomes: Characteristics and Applications in Disease Pathology and Management,” Life Sciences 342 (2024): 122542.

[105] F. Rossiello, D. Jurk, J. F. Passos, and F. d'Adda di Fagagna, “Telomere Dysfunction in Ageing and Age-Related Diseases,” Nature Cell Biology 24, no. 2 (2022): 135-147.

[106] Q. Zhang, X. Shen, X. Yuan, et al., “Lipopolysaccharide Binding Protein Resists Hepatic Oxidative Stress by Regulating Lipid Droplet Homeostasis,” Nature Communications 15, no. 1 (2024): 3213.

[107] R. Tian, A. Abarientos, J. Hong, et al., “Genome-Wide CRISPRi/a Screens in Human Neurons Link Lysosomal Failure to Ferroptosis,” Nature Neuroscience 24, no. 7 (2021): 1020-1034.

[108] J. J. Lee, “Galangin Reverses H(2)O(2)-induced Dermal Fibroblast Senescence via SIRT1-PGC-1α/Nrf2 Signaling,” International Journal of Molecular Sciences 23, no. 3 (2022): 1387.

[109] Y. Zhang, X. Bai, K. Shen, et al., “Exosomes Derived From Adipose Mesenchymal Stem Cells Promote Diabetic Chronic Wound Healing Through SIRT3/SOD2,” Cells 11, no. 16 (2022): 2568.

[110] F. U. R. Bhatti, S. J. Kim, A. K. Yi, K. A. Hasty, and H. Cho, “Cytoprotective Role of Vitamin E in Porcine Adipose-Tissue-Derived Mesenchymal Stem Cells Against Hydrogen-Peroxide-Induced Oxidative Stress,” Cell and Tissue Research 374, no. 1 (2018): 111-120.

[111] I. Buendia, P. Michalska, E. Navarro, I. Gameiro, J. Egea, and R. León, “Nrf2-ARE Pathway: An Emerging Target Against Oxidative Stress and Neuroinflammation in Neurodegenerative Diseases,” Pharmacology and Therapeutics 157 (2016): 84-104.

[112] Y. Hu, R. Tao, L. Wang, et al., “Exosomes Derived From Bone Mesenchymal Stem Cells Alleviate Compression-Induced Nucleus Pulposus Cell Apoptosis by Inhibiting Oxidative Stress,” Oxidative Medicine and Cellular Longevity 2021 (2021): 2310025.

[113] T. Huang, H. Tong, H. Zhou, et al., “ADSC-Exosomes Alleviate MTX-Induced Rat Neuronal Damage by Activating Nrf2-ARE Pathway,” Journal of Molecular Neuroscience 72, no. 6 (2022): 1334-1344.

[114] H. Q. Xin, Z. Liu, B. Buller, et al., “MiR-17-92 Enriched Exosomes Derived From Multipotent Mesenchymal Stromal Cells Enhance Axon-Myelin Remodeling and Motor Electrophysiological Recovery After Stroke,” Journal of Cerebral Blood Flow and Metabolism 41, no. 5 (2021): 1131-1144.

[115] G. Filomeni, D. De Zio, and F. Cecconi, “Oxidative Stress and Autophagy: The Clash Between Damage and Metabolic Needs,” Cell Death and Differentiation 22, no. 3 (2015): 377-388.

[116] I. Lekli, D. D. Haines, G. Balla, and A. Tosaki, “Autophagy: An Adaptive Physiological Countermeasure to Cellular Senescence and Ischaemia/Reperfusion-Associated Cardiac Arrhythmias,” Journal of Cellular and Molecular Medicine 21, no. 6 (2017): 1058-1072.

[117] Z. Hu, Y. Yuan, X. Zhang, et al., “Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Attenuate Oxygen-Glucose Deprivation/Reperfusion-Induced Microglial Pyroptosis by Promoting FOXO3a-Dependent Mitophagy,” Oxidative Medicine and Cellular Longevity 2021, no. 1 (2021): 6219715.

[118] H. Lavoie, J. Gagnon, and M. Therrien, “ERK Signalling: A Master Regulator of Cell Behaviour, Life and Fate,” Nature Reviews Molecular Cell Biology 21, no. 10 (2020): 607-632.

[119] Y. Sun, W. Z. Liu, T. Liu, X. Feng, N. Yang, and H. F. Zhou, “Signaling Pathway of MAPK/ERK in Cell Proliferation, Differentiation, Migration, Senescence and Apoptosis,” Journal of Receptors and Signal Transduction 35, no. 6 (2015): 600-604.

[120] Y. R. Jiao, K. X. Chen, X. Tang, et al., “Exosomes Derived From Mesenchymal Stem Cells in Diabetes and Diabetic Complications,” Cell Death and Disease 15, no. 4 (2024): 271.

[121] M. Huang, Y. Liu, L. Zhang, S. Wang, X. Wang, and Z. He, “Advancements in Research on Mesenchymal Stem-Cell-Derived Exosomal miRNAs: A Pivotal Insight Into Aging and Age-Related Diseases,” Biomolecules 11, no. 14 (2004): 1354.

[122] F. Yang, Y. Wu, Y. Chen, et al., “Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Ameliorate Liver Steatosis by Promoting Fatty Acid Oxidation and Reducing Fatty Acid Synthesis,” JHEP Reports 5, no. 7 (2023): 100746.

[123] Z. Gong, Z. Shu, Y. Zhou, Y. Chen, and H. Zhu, “KLF2 Regulates Stemness of Human Mesenchymal Stem Cells by Targeting FGFR3,” Biotechnic and Histochemistry 98, no. 7 (2023): 447-455.

[124] K. Kolacz and A. Robaszkiewicz, “PARP1 at the Crossroad of Cellular Senescence and Nucleolar Processes,” Ageing Research Reviews 94 (2024): 102206.

[125] J. Xie, W. Wu, L. Zheng, et al., “Roles of MicroRNA-21 in Skin Wound Healing: A Comprehensive Review,” Frontiers in Pharmacology 13 (2022): 828627.

[126] H. Kang, B. N. Davis-Dusenbery, P. H. Nguyen, et al., “Bone Morphogenetic Protein 4 Promotes Vascular Smooth Muscle Contractility by Activating MicroRNA-21 (miR-21), which Down-Regulates Expression of Family of Dedicator of Cytokinesis (DOCK) Proteins,” Journal of Biological Chemistry 287, no. 6 (2012): 3976-3986.

[127] C. Tan, M. Song, W. D. Stamer, et al., “miR-21-5p: A Viable Therapeutic Strategy for Regulating Intraocular Pressure,” Experimental Eye Research 200 (2020): 108197.

[128] Y. Yin, H. Chen, Y. Wang, L. Zhang, and X. Wang, “Roles of Extracellular Vesicles in the Aging Microenvironment and Age-Related Diseases,” Journal of Extracellular Vesicles 10, no. 12 (2021): e12154.

[129] J. Giroud, I. Bouriez, H. Paulus, A. Pourtier, F. Debacq-Chainiaux, and O. Pluquet, “Exploring the Communication of the SASP: Dynamic, Interactive, and Adaptive Effects on the Microenvironment,” International Journal of Molecular Sciences 24, no. 13 (2023): 10788.

[130] Q. Tan, N. Liang, X. Zhang, and J. Li, “Dynamic Aging: Channeled Through Microenvironment,” Frontiers in Physiology 12 (2021): 702276.

[131] D. V. Ziegler, C. D. Wiley, and M. C. Velarde, “Mitochondrial Effectors of Cellular Senescence: Beyond the Free Radical Theory of Aging,” Aging Cell 14, no. 1 (2015): 1-7.

[132] É. Kevei and T. Hoppe, “Ubiquitin Sets the Timer: Impacts on Aging and Longevity,” Nature Structural and Molecular Biology 21, no. 4 (2014): 290-292.

[133] T. Wang, Z. Jian, A. Baskys, et al., “MSC-Derived Exosomes Protect Against Oxidative Stress-Induced Skin Injury via Adaptive Regulation of the NRF2 Defense System,” Biomaterials 257 (2020): 120264.

[134] Z. M. Wu and K. L. Guan, “Hippo Signaling in Embryogenesis and Development,” Trends in Biochemical Sciences 46, no. 1 (2021): 51-63.

[135] Y. G. Zheng and D. J. Pan, “The Hippo Signaling Pathway in Development and Disease,” Developmental Cell 50, no. 3 (2019): 264-282.

[136] X. Cao, P. Luo, J. Huang, et al., “Intraarticular Senescent Chondrocytes Impair the Cartilage Regeneration Capacity of Mesenchymal Stem Cells,” Stem Cell Research and Therapy 10, no. 1 (2019): 86.

[137] S. Wakale, X. Wu, Y. Sonar, et al., “How Are Aging and Osteoarthritis Related?,” Aging and Disease 14, no. 3 (2023): 592-604.

[138] N. Jiang, B. Xing, R. Peng, et al., “Inhibition of Cpt1a Alleviates Oxidative Stress-Induced Chondrocyte Senescence via Regulating Mitochondrial Dysfunction and Activating Mitophagy,” Mechanisms of Ageing and Development 205 (2022): 111688.

[139] P. R. Coryell, B. O. Diekman, and R. F. Loeser, “Mechanisms and Therapeutic Implications of Cellular Senescence in Osteoarthritis,” Nature Reviews Rheumatology 17, no. 1 (2021): 47-57.

[140] K. Rilla, A. M. Mustonen, U. T. Arasu, K. Härkönen, J. Matilainen, and P. Nieminen, “Extracellular Vesicles Are Integral and Functional Components of the Extracellular Matrix,” Matrix Biology 75 (2019): 201-219.

[141] W. Zhang, X. Bai, B. Zhao, et al., “Cell-Free Therapy Based on Adipose Tissue Stem Cell-Derived Exosomes Promotes Wound Healing via the PI3K/Akt Signaling Pathway,” Experimental Cell Research 370, no. 2 (2018): 333-342.

[142] M. J. Kuang, Y. Huang, X. G. Zhao, et al., “Exosomes Derived From Wharton's Jelly of Human Umbilical Cord Mesenchymal Stem Cells Reduce Osteocyte Apoptosis in Glucocorticoid-Induced Osteonecrosis of the Femoral Head in Rats via the miR-21-PTEN-AKT Signalling Pathway,” International Journal of Biological Sciences 15, no. 9 (2019): 1861-1871.

[143] Y. Liu, P. Lei, R. Z. Samuel, et al., “Cadherin-11 Increases Tumor Cell Proliferation and Metastatic Potential via Wnt Pathway Activation,” Molecular Oncology 17, no. 10 (2023): 2056-2073.

[144] S. Fang, T. He, J. Jiang, Y. Li, and P. Chen, “Osteogenic Effect of tsRNA-10277-Loaded Exosome Derived From Bone Mesenchymal Stem Cells on Steroid-Induced Osteonecrosis of the Femoral Head,” Drug Design, Development and Therapy 14 (2020): 4579-4591.

[145] J. O. Abaricia, A. H. Shah, M. Chaubal, K. M. Hotchkiss, and R. Olivares-Navarrete, “Wnt Signaling Modulates Macrophage Polarization and Is Regulated by Biomaterial Surface Properties,” Biomaterials 243 (2020): 119920.

[146] K. Jiang, T. Jiang, Y. Chen, and X. Mao, “Mesenchymal Stem Cell-Derived Exosomes Modulate Chondrocyte Glutamine Metabolism to Alleviate Osteoarthritis Progression,” Mediators of Inflammation 2021, no. 1 (2021): 2979124.

[147] L. A. Vonk, S. F. J. van Dooremalen, N. Liv, et al., “Mesenchymal Stromal/Stem Cell-Derived Extracellular Vesicles Promote Human Cartilage Regeneration in Vitro,” Theranostics 8, no. 4 (2018): 906-920.

[148] A. J. Millis, M. Hoyle, H. M. McCue, and H. Martini, “Differential Expression of Metalloproteinase and Tissue Inhibitor of Metalloproteinase Genes in Aged Human Fibroblasts,” Experimental Cell Research 201, no. 2 (1992): 373-379.

[149] S. J. Cooper and G. T. Bowden, “Ultraviolet B Regulation of Transcription Factor Families: Roles of Nuclear Factor-Kappa B (NF-kappaB) and Activator Protein-1 (AP-1) in UVB-Induced Skin Carcinogenesis,” Current Cancer Drug Targets 7, no. 4 (2007): 325-334.

[150] G. J. Fisher, S. C. Datta, H. S. Talwar, et al., “Molecular Basis of Sun-Induced Premature Skin Ageing and Retinoid Antagonism,” Nature 379, no. 6563 (1996): 335-339.

[151] M. Wlaschek, P. Maity, E. Makrantonaki, and K. Scharffetter-Kochanek, “Connective Tissue and Fibroblast Senescence in Skin Aging,” Journal of Investigative Dermatology 141, no. 4S (2021): 985-992.

[152] M. Li, X. Li, B. Liu, et al., “Time-Resolved Extracellular Matrix Atlas of the Developing Human Skin Dermis,” Frontiers in Cell and Developmental Biology 9 (2021): 783456.

[153] J. Burk, A. Sassmann, C. Kasper, A. Nimptsch, and S. Schubert, “Extracellular Matrix Synthesis and Remodeling by Mesenchymal Stromal Cells Is Context-Sensitive,” International Journal of Molecular Sciences 23, no. 3 (2022): 1758.

[154] Y. Ju, Y. Hu, P. Yang, X. Xie, and B. Fang, “Extracellular Vesicle-Loaded Hydrogels for Tissue Repair and Regeneration,” Materials Today Bio 18 (2023): 100522.

[155] B. Zhang, L. Shen, H. Shi, et al., “Exosomes From Human Umbilical Cord Mesenchymal Stem Cells: Identification, Purification, and Biological Characteristics,” Stem Cells International 2016 (2016): 1929536.

[156] L. Groban, N. A. Pailes, C. D. L. Bennett, et al., “Growth Hormone Replacement Attenuates Diastolic Dysfunction and Cardiac Angiotensin II Expression in Senescent Rats,” Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 61, no. 1 (2006): 28-35.

[157] L. Liberale, F. Montecucco, L. Schwarz, T. F. Lüscher, and G. G. Camici, “Inflammation and Cardiovascular Diseases: Lessons From Seminal Clinical Trials,” Cardiovascular Research 117, no. 2 (2021): 411-422.

[158] A. Walaszczyk, E. Dookun, R. Redgrave, et al., “Pharmacological Clearance of Senescent Cells Improves Survival and Recovery in Aged Mice Following Acute Myocardial Infarction,” Aging Cell 18, no. 3 (2019): e12945.

[159] S. I. Bloom, M. T. Islam, L. A. Lesniewski, and A. J. Donato, “Mechanisms and Consequences of Endothelial Cell Senescence,” Nature Reviews Cardiology 20, no. 1 (2023): 38-51.

[160] W. Yan, Y. Xia, H. Zhao, X. Xu, X. Ma, and L. Tao, “Stem Cell-Based Therapy in Cardiac Repair After Myocardial Infarction: Promise, Challenges, and Future Directions,” Journal of Molecular and Cellular Cardiology 188 (2024): 1-14.

[161] J. Li, H. Xue, T. Li, et al., “Exosomes Derived From Mesenchymal Stem Cells Attenuate the Progression of Atherosclerosis in ApoE(−/−) Mice via miR-let7 Mediated Infiltration and Polarization of M2 Macrophage,” Biochemical and Biophysical Research Communications 510, no. 4 (2019): 565-572.

[162] F. Yan, W. Cui, and Z. Chen, “Mesenchymal Stem Cell-Derived Exosome-Loaded microRNA-129-5p Inhibits TRAF3 Expression to Alleviate Apoptosis and Oxidative Stress in Heart Failure,” Cardiovascular Toxicology 22, no. 7 (2022): 631-645.

[163] H. Yu, Y. Pan, M. Dai, X. Wang, and H. Chen, “Mesenchymal Stem Cell-Originated Exosomal Lnc A2M-AS1 Alleviates Hypoxia/Reperfusion-Induced Apoptosis and Oxidative Stress in Cardiomyocytes,” Cardiovascular Drugs and Therapy 37, no. 5 (2023): 891-904.

[164] Y. Wang, N. Ding, G. Guan, et al., “Rapid Delivery of Hsa-miR-590-3p Using Targeted Exosomes to Treat Acute Myocardial Infarction Through Regulation of the Cell Cycle,” Journal of Biomedical Nanotechnology 14, no. 5 (2018): 968-977.

[165] W. Li, Y. Liu, P. Zhang, et al., “Tissue-Engineered Bone Immobilized With Human Adipose Stem Cells-Derived Exosomes Promotes Bone Regeneration,” ACS Applied Materials and Interfaces 10, no. 6 (2018): 5240-5254.

[166] J. G. He, H. R. Li, J. X. Han, et al., “GATA-4-Expressing Mouse Bone Marrow Mesenchymal Stem Cells Improve Cardiac Function After Myocardial Infarction via Secreted Exosomes,” Scientific Reports 8, no. 1 (2018): 9047.

[167] M. A. Lovell, S. P. Gabbita, and W. R. Markesbery, “Increased DNA Oxidation and Decreased Levels of Repair Products in Alzheimer's Disease Ventricular CSF,” Journal of Neurochemistry 72, no. 2 (1999): 771-776.

[168] L. Weissman, D. G. Jo, M. M. Sorensen, et al., “Defective DNA Base Excision Repair in Brain From Individuals With Alzheimer's Disease and Amnestic Mild Cognitive Impairment,” Nucleic Acids Research 35, no. 16 (2007): 5545-5555.

[169] T. A. Banarase, S. S. Sammeta, N. L. Wankhede, et al., “Mitophagy Regulation in Aging and Neurodegenerative Disease,” Biophysical Reviews 15, no. 2 (2023): 239-255.

[170] X. Gao, Q. Chen, H. Yao, et al., “Epigenetics in Alzheimer's Disease,” Frontiers in Aging Neuroscience 14 (2022): 911635.

[171] W. E. Allen, T. R. Blosser, Z. A. Sullivan, C. Dulac, and X. Zhuang, “Molecular and Spatial Signatures of Mouse Brain Aging at Single-Cell Resolution,” Cell 186, no. 1 (2023): 194-208.

[172] M. Nakano, K. Kubota, E. Kobayashi, et al., “Bone Marrow-Derived Mesenchymal Stem Cells Improve Cognitive Impairment in an Alzheimer's Disease Model by Increasing the Expression of microRNA-146a in Hippocampus,” Scientific Reports 10, no. 1 (2020): 10772.

[173] G. El Bassit, R. S. Patel, G. Carter, et al., “MALAT1 in Human Adipose Stem Cells Modulates Survival and Alternative Splicing of PKCδII in HT22 Cells,” Endocrinology 158, no. 1 (2017): 183-195.

[174] K. Nazimek, I. Filipczak-Bryniarska, and K. Bryniarski, “The Role of Medicaments, Exosomes and miRNA Molecules in Modulation of Macrophage Immune Activity,” Postȩpy Higieny i Medycyny Doświadczalnej (Online) 69 (2015): 1114-1129.

[175] S. Liu, M. Fan, J. X. Xu, et al., “Exosomes Derived From Bone-Marrow Mesenchymal Stem Cells Alleviate Cognitive Decline in AD-Like Mice by Improving BDNF-Related Neuropathology,” Journal of Neuroinflammation 19, no. 1 (2022): 35.

[176] S. He, Q. Wang, L. Chen, Y. J. He, X. Wang, and S. Qu, “miR-100a-5p-Enriched Exosomes Derived From Mesenchymal Stem Cells Enhance the Anti-Oxidant Effect in a Parkinson's Disease Model via Regulation of Nox4/ROS/Nrf2 Signaling,” Journal of Translational Medicine 21, no. 1 (2023): 747.

[177] Y. Jahangard, H. Monfared, A. Moradi, M. Zare, J. Mirnajafi-Zadeh, and S. J. Mowla, “Therapeutic Effects of Transplanted Exosomes Containing miR-29b to a Rat Model of Alzheimer's Disease,” Frontiers in Neuroscience 14 (2020): 564.

[178] J. Wang, Y. Teng, G. Zhao, et al., “Exosome-Mediated Delivery of Inducible miR-423-5p Enhances Resistance of MRC-5 Cells to Rabies Virus Infection,” International Journal of Molecular Sciences 20, no. 7 (2019): 1537.

[179] H. H. Kwon, S. H. Yang, J. Lee, et al., “Combination Treatment With Human Adipose Tissue Stem Cell-Derived Exosomes and Fractional CO2 Laser for Acne Scars: A 12-Week Prospective, Double-Blind, Randomized, Split-Face Study,” Acta Dermato-Venereologica 100, no. 18 (2020): adv00310.

RIGHTS & PERMISSIONS

2024 The Author(s). Cell Proliferation published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley & Sons Ltd.